Literature DB >> 22493997

Beyond the distinction between biomedical and social dimensions of HIV prevention through the lens of a social public health.

Susan Kippax1, Niamh Stephenson.   

Abstract

Developing effective HIV prevention requires that we move beyond the historical but problematic distinction between biomedical and social dimensions of HIV. The current claim that prevention has failed has led to a strong interest in the role of treatment as HIV prevention; however, the turn to "biomedical prevention," "test and treat," and "combination prevention" instances pervasive confusions about prevention. These confusions arise from a failure to realize that all HIV prevention interventions must engage with the everyday lives of people and be integrated into their social relations and social practices. We challenge the claim that prevention has failed (illustrating this with discussion of prevention in Australia, Uganda, and Zimbabwe). We explain the enduring appeal of misguided approaches to prevention by examining how 1996 can be seen as a pivotal moment in the history of the global response to HIV, a moment marked by the rise and fall of distinct biomedical and social narratives of HIV.

Entities:  

Mesh:

Year:  2012        PMID: 22493997      PMCID: PMC3483918          DOI: 10.2105/AJPH.2011.300594

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  29 in total

1.  Interim guidance: preexposure prophylaxis for the prevention of HIV infection in men who have sex with men.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2011-01-28       Impact factor: 17.586

2.  Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women.

Authors:  Quarraisha Abdool Karim; Salim S Abdool Karim; Janet A Frohlich; Anneke C Grobler; Cheryl Baxter; Leila E Mansoor; Ayesha B M Kharsany; Sengeziwe Sibeko; Koleka P Mlisana; Zaheen Omar; Tanuja N Gengiah; Silvia Maarschalk; Natasha Arulappan; Mukelisiwe Mlotshwa; Lynn Morris; Douglas Taylor
Journal:  Science       Date:  2010-07-19       Impact factor: 47.728

3.  A social public health.

Authors:  Niamh Stephenson
Journal:  Am J Public Health       Date:  2011-07       Impact factor: 9.308

Review 4.  HIV prevention transformed: the new prevention research agenda.

Authors:  Nancy S Padian; Sandra I McCoy; Salim S Abdool Karim; Nina Hasen; Julia Kim; Michael Bartos; Elly Katabira; Stefano M Bertozzi; Bernhard Schwartländer; Myron S Cohen
Journal:  Lancet       Date:  2011-07-16       Impact factor: 79.321

5.  Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial.

Authors:  Robert C Bailey; Stephen Moses; Corette B Parker; Kawango Agot; Ian Maclean; John N Krieger; Carolyn F M Williams; Richard T Campbell; Jeckoniah O Ndinya-Achola
Journal:  Lancet       Date:  2007-02-24       Impact factor: 79.321

6.  Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based study.

Authors:  Julio S G Montaner; Viviane D Lima; Rolando Barrios; Benita Yip; Evan Wood; Thomas Kerr; Kate Shannon; P Richard Harrigan; Robert S Hogg; Patricia Daly; Perry Kendall
Journal:  Lancet       Date:  2010-07-16       Impact factor: 79.321

7.  Is HIV/AIDS stigma dividing the gay community? Perceptions of HIV-positive men who have sex with men.

Authors:  Cari Courtenay-Quirk; Richard J Wolitski; Jeffrey T Parsons; Cynthia A Gómez
Journal:  AIDS Educ Prev       Date:  2006-02

Review 8.  Behavioural strategies to reduce HIV transmission: how to make them work better.

Authors:  Thomas J Coates; Linda Richter; Carlos Caceres
Journal:  Lancet       Date:  2008-08-05       Impact factor: 79.321

Review 9.  Modelling sexual transmission of HIV: testing the assumptions, validating the predictions.

Authors:  Rebecca F Baggaley; Christophe Fraser
Journal:  Curr Opin HIV AIDS       Date:  2010-07       Impact factor: 4.283

Review 10.  Antiretroviral post-exposure prophylaxis (PEP) for occupational HIV exposure.

Authors:  T N Young; F J Arens; G E Kennedy; J W Laurie; G w Rutherford
Journal:  Cochrane Database Syst Rev       Date:  2007-01-24
View more
  47 in total

1.  Between individual agency and structure in HIV prevention: understanding the middle ground of social practice.

Authors:  Susan Kippax; Niamh Stephenson; Richard G Parker; Peter Aggleton
Journal:  Am J Public Health       Date:  2013-06-13       Impact factor: 9.308

2.  The Significance of Harm Reduction as a Social and Health Care Intervention for Injecting Drug Users: An Exploratory Study of a Needle Exchange Program in Fresno, California.

Authors:  Kris Clarke; Debra Harris; John A Zweifler; Marc Lasher; Roger B Mortimer; Susan Hughes
Journal:  Soc Work Public Health       Date:  2016-05-11

Review 3.  Planning ahead for implementation of long-acting HIV prevention: challenges and opportunities.

Authors:  Kathrine Meyers; Sarit A Golub
Journal:  Curr Opin HIV AIDS       Date:  2015-07       Impact factor: 4.283

4.  Moving Beyond Biomedicalization in the HIV Response: Implications for Community Involvement and Community Leadership Among Men Who Have Sex with Men and Transgender People.

Authors:  Peter Aggleton; Richard Parker
Journal:  Am J Public Health       Date:  2015-06-11       Impact factor: 9.308

5.  Biomedical and social dimensions of HIV prevention.

Authors:  Sevgi O Aral; James Blanchard
Journal:  Am J Public Health       Date:  2012-07-19       Impact factor: 9.308

Review 6.  Clinical uncertainties, health service challenges, and ethical complexities of HIV "test-and-treat": a systematic review.

Authors:  Sonali P Kulkarni; Kavita R Shah; Karthik V Sarma; Anish P Mahajan
Journal:  Am J Public Health       Date:  2013-04-18       Impact factor: 9.308

7.  Fiscal loss and program fidelity: impact of the economic downturn on HIV/STI prevention program fidelity.

Authors:  Joseph A Catania; M Margaret Dolcini; Alice A Gandelman; Vasudha Narayanan; Virginia R McKay
Journal:  Transl Behav Med       Date:  2014-03       Impact factor: 3.046

8.  Preparing for rectal microbicides: sociocultural factors affecting product uptake among potential South American users.

Authors:  Jerome T Galea; Janni J Kinsler; John Imrie; César R Nureña; Lucía Ruiz; Luis Fernando Galarza; Jorge Sánchez; William E Cunningham
Journal:  Am J Public Health       Date:  2014-04-17       Impact factor: 9.308

Review 9.  State of the science of adherence in pre-exposure prophylaxis and microbicide trials.

Authors:  Felix M Muchomba; Robin E Gearing; Jane M Simoni; Nabila El-Bassel
Journal:  J Acquir Immune Defic Syndr       Date:  2012-12-01       Impact factor: 3.731

10.  The Flawed Reliance on Randomized Controlled Trials in Studies of HIV Behavioral Prevention Interventions for People Who Inject Drugs and Other Populations.

Authors:  Samuel R Friedman; David C Perlman; Danielle C Ompad
Journal:  Subst Use Misuse       Date:  2015-07-29       Impact factor: 2.164

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.